Filter
614
Text search:
latent
tuberculosis
Featured
Recommendations
66
New Publications
151
Language
Document type
No document type
455
Guidelines
57
Studies & Reports
52
Manuals
21
Fact sheets
11
Strategic & Response Plan
8
Training Material
6
Situation Updates
2
Infographics
1
Online Courses
1
Countries / Regions
Western and Central Europe
41
India
22
Eastern Europe
21
South Africa
16
Tanzania
13
Nepal
12
Germany
11
Kenya
11
Latin America and the Carribbean
9
Nigeria
8
Ethiopia
8
Global
8
Namibia
7
Zambia
6
Ukraine
6
Myanmar / Burma
6
Bangladesh
5
South–East Asia Region
5
Russia
5
Ghana
4
Cambodia
4
Rwanda
4
Malawi
4
Argentina
4
Colombia
4
Botswana
4
Asia
4
Sierra Leone
3
Liberia
3
Uganda
3
Philippines
3
Africa
3
USA
2
Cameroon
2
El Salvador
2
Lesotho
2
East and Southern Africa
2
Albania
2
Timor Leste/ East Timor
2
North America
2
Guinea
1
Senegal
1
Guinea-Bissau
1
Zimbabwe
1
South Sudan
1
Thailand
1
Gambia
1
China
1
Indonesia
1
Mozambique
1
Peru
1
Eswatini/ Swaziland
1
Brazil
1
Switzerland
1
Angola
1
Sri Lanka
1
West and Central Africa
1
Middle East and North Africa
1
Western Pacific Region
1
Bhutan
1
North Korea
1
Laos
1
Estonia
1
Romania
1
Moldova
1
Iran
1
Georgia
1
Vietnam
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
164
Clinical Guidelines
74
Public Health
20
Women & Child Health
11
Pharmacy & Technologies
6
Key Resources
5
Capacity Building
4
Toolboxes
TB
332
HIV
77
Refugee
19
Polio
12
COVID-19
11
Pharmacy
8
Mental Health
6
NTDs
6
Ebola & Marburg
5
AMR
5
Caregiver
5
Planetary Health
5
Global Health Education
4
NCDs
4
Malaria
4
Conflict
2
Rapid Response
2
Zika
1
2.0 Rapid Response
1
MMWR. Recommendations and Reports:
December 16, 2005 / 54(RR15);49-55
Euro Surveill. 2016;21(12):pii=30174. DOI: http://dx.doi.org/10.2807/1560-7917.ES.2016.21.12.30174
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
WHO consolidated guidelines on tuberculosis: module 1: prevention: tuberculosis preventive treatment
The 2020 recommendations for the programmatic management of TB preventive treatment are the first to be released under the rubric of WHO consolidated TB guidelines (Module 1 – Prevention). The WHO consolidated TB guidelines will gradually group all TB recommendations and will be complemented by ma
...
BMC Infectious Diseases 2012, 12:352/1471-2334/12/352
The main objective of these guidelines is to provide guidance on up-to-date, uniform, evidence-informed practices for suspecting, diagnosing and managing various forms of extra-pulmonary tuberculosis (EPTB) at all levels of healthcare delivery. They
...
Facilitator's Guide. This guide is designed to assist facilitators in training community health workers (CHWs) and community volunteers (CVs) in integrating community-based TB services into their work. The training will help community workers who already provide numerous services to understand TB an
...
13 May 2021
To avoid a reversal of progress from the adverse impacts of the COVID-19 pandemic, new knowledge and lessons from successful programmatic innovations are urgently needed to improve TB prevention and care. Experience can provide evidence for innovative approaches and strategies to mainta
...
A Guide for low income countries
International Journal of Drug Policy 24 (2013) e91-98
The present Consolidated guidelines include a comprehensive set of WHO recommendations for the treatment and care of DR-TB, derived from these WHO guidelines documents. The consolidated guidelines include policy recommendations on treatment regimens for isoniazid-resistant TB (Hr-TB) and MDR/RR-TB,
...
he WHO South-East Region in 2019 accounted for nearly a million missing TB patients from the estimated incidence. Active case-finding (ACF) or systematic screening for tuberculosis is an important tool to reach out to missing TB patients. When appro
...